Literature DB >> 2245181

Prognostic factors for survival in soft tissue sarcoma.

J N el-Jabbour1, S S Akhtar, G R Kerr, K M McLaren, J F Smyth, A Rodger, R C Leonard.   

Abstract

Between 1975 and 1984, 125 cases of histologically confirmed soft tissue sarcomata (STS) were registered in the Department of Clinical Oncology in Edinburgh. Of these, 100 were eligible for analysis of prognostic factors. The overall 5-year survival rate was 21.5%. Univariate analysis demonstrated that extent of surgery, radical versus palliative or no radiotherapy, mass as a presenting symptom, metastases at presentation, site, histological type, mitotic activity, grade and UICC stage all had a statistically significant effect on survival. Analysis using the proportional hazard regression model was performed on the 87 patients for whom all variables were recorded. When all histological and clinical features and treatment modalities were included in the model then radiotherapy, surgery, necrosis, sex and mitoses were identified as independent prognostic variables. When symptoms and treatment were excluded then the multivariate analysis identified sex and mitotic activity as independent parameters. For the 33 superficial STS with tumour size recorded multivariate analysis revealed size, necrosis and cellularity as independent prognostic variables. For the 31 deep STS histological type, sex, surgery and radiotherapy were identified as independent prognostic parameters.

Entities:  

Mesh:

Year:  1990        PMID: 2245181      PMCID: PMC1971531          DOI: 10.1038/bjc.1990.394

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Soft tissue tumours: their natural history and treatment.

Authors:  S CADE
Journal:  Proc R Soc Med       Date:  1951-01

2.  A retrospective study of the role of radiotherapy in the treatment of soft-tissue sarcoma.

Authors:  J A Dewar; W Duncan
Journal:  Clin Radiol       Date:  1985-11       Impact factor: 2.350

3.  The management of soft-tissue sarcomas of the extremities.

Authors:  M A Simon; W F Enneking
Journal:  J Bone Joint Surg Am       Date:  1976-04       Impact factor: 5.284

4.  Surgical treatment of 297 soft tissue sarcomas of the lower extremity.

Authors:  M H Shiu; E B Castro; S I Hajdu; J G Fortner
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

5.  Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.

Authors:  C Collin; J Godbold; S Hajdu; M Brennan
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

6.  The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases.

Authors:  J Costa; R A Wesley; E Glatstein; S A Rosenberg
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

7.  Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors.

Authors:  H W Heise; M H Myers; W O Russell; H D Suit; F M Enzinger; J H Edmonson; J Cohen; R G Martin; W T Miller; S I Hajdu
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

8.  Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma.

Authors:  T Ueda; K Aozasa; M Tsujimoto; H Hamada; H Hayashi; K Ono; K Matsumoto
Journal:  Cancer       Date:  1988-10-01       Impact factor: 6.860

Review 9.  Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases.

Authors:  A M Mandard; J F Petiot; J Marnay; J C Mandard; J Chasle; E de Ranieri; P Dupin; P Herlin; J de Ranieri; A Tanguy
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

10.  Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester.

Authors:  V H Bramwell; D Crowther; D P Deakin; R Swindell; M Harris
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

View more
  6 in total

1.  Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Authors:  P Rudolph; U Kellner; A Chassevent; F Collin; F Bonichon; R Parwaresch; J M Coindre
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Patients with soft-tissue sarcomas.

Authors:  P F Choong; A Rydholm; P Gustafson
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

3.  A retrospective statistical analysis of high-grade soft tissue sarcomas.

Authors:  Gregory G Kolovich; Adam N Wooldridge; Jonathan M Christy; Martha K Crist; Joel L Mayerson; Thomas J Scharschmidt
Journal:  Med Oncol       Date:  2011-05-07       Impact factor: 3.064

4.  Soft tissue leiomyosarcoma-diagnostics, management, and prognosis: Data of the registry cancer of the center of Tunisia.

Authors:  Sarra Mestiri; Mohamed Amine Elghali; Rym Bourigua; Nihed Abdessayed; Salsabil Nasri; Ben Abdallah Amine; Nabiha Missaoui; Mahmoud Ben Maitig; Sihem Hmissa; Badreddine Sriha; Moncef Mokni
Journal:  Rare Tumors       Date:  2019-01-21

5.  Sarcomas in north west England: III. Survival.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

6.  Frailty in Very Elderly Patients is Not Associated with Adverse Surgical or Oncological Outcomes in Extremity Surgery for Soft Tissue Sarcoma.

Authors:  Gausihi Sivarajah; Emma Davies; Anna Hurley; Dirk C Strauss; Myles J F Smith; Andrew J Hayes
Journal:  Ann Surg Oncol       Date:  2022-02-03       Impact factor: 4.339

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.